首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Overexpression of angiotensin ll type l receptor in pression of angiotensin ll type l receptor in cardiomvocytes induces cardiac hypertrophy and remodeling
【24h】

Overexpression of angiotensin ll type l receptor in pression of angiotensin ll type l receptor in cardiomvocytes induces cardiac hypertrophy and remodeling

机译:血管紧张素II型受体的过表达在心肌细胞中的血管紧张素II型受体的表达诱导心肌肥大和重塑

获取原文
获取原文并翻译 | 示例
       

摘要

Angiotensin lI (All) is a major determinant of arterial pressure and volume homeostasis, mainly because of its vascular action via the All type 1 receptor (AT1R). All has also been implicated in the development of cardiac hypertrophy because angiotensin l-con- verting enzyme inhibitors and AT1 R antagonists prevent or regress ventricular hypertrophy in animal models and in human. However, because these treatments impede the action of All at cardiac as well as vascular levels. and reduce blood pressure, it has been difficult to determine whether All action on the heart is direct or a consequence of pressure-overload. To determine whether All can induce cardiac hypertrophy directly via myocardial AT1R in the absence of vascular changes, transgenic mice overexpressing the human AT1 R under the control of the mouse alpha-myosin heavy chain promoter were generated. Cardiomyocyte-specific overexpression of AT1R induced, in basal conditions, morphologic changes of myocytes and nonmyocytes that mimic those observed during the development of cardiac hypertrophy in human and in other mam- mals. These mice displayed significant cardiac hypertrophy and remodeling with increased expression of ventricular atrial natri- uretic factor and interstitiaI collagen deposition and died prema- turely of heart failure. Neither the systolic blood pressure nor the heart rate were changed. The data demonstrate a direct myocardial role for All in the development of cardiac hypertrophy and failure and provide a useful model to elucidate the mechanisms of action of All in the pathogenesis of cardiac diseases.
机译:血管紧张素II(All)是决定动脉压和动态平衡的主要因素,主要是由于其通过All 1型受体(AT1R)的血管作用。由于血管紧张素I转换酶抑制剂和AT1 R拮抗剂可预防或逆转动物模型和人类的心室肥大,因此所有这些都与心脏肥大的发生有关。但是,由于这些治疗会阻碍All在心脏和血管水平上的作用。并且降低血压,很难确定对心脏的所有作用是直接的还是压力超负荷的结果。为了确定在没有血管变化的情况下All是否可以直接通过心肌AT1R诱导心肌肥大,产生了在小鼠α-肌球蛋白重链启动子控制下过表达人AT1R的转基因小鼠。在基础条件下,AT1R的心肌细胞特异性过表达诱导了模仿人类和其他哺乳动物心脏肥大过程中观察到的形态的肌细胞和非肌细胞的形态变化。这些小鼠表现出明显的心脏肥大和重塑,心室心钠素表达增加和间质胶原沉积,并死于心力衰竭。收缩压和心率均未改变。数据证明了All在心肌肥大和衰竭发展中的直接心肌作用,并为阐明All在心脏病发病机理中的作用机制提供了有用的模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号